COZADD BRUCE C — SEC insider filings
SEC reporting owner CIK 1193210. 74 insider filings on record with FilingPulse; latest filed 2026-11-10.
Transaction summary — filings shown
Covers the 50 most recent of 74 filings on record, filed 2022-03-21 to 2026-11-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 79 legs across 35 filings — 349,666 shares, $63,985,710 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 53.
- Largest priced transaction: sale of 38,126 shares @ $177.27 ($6,758,672) in Jazz Pharmaceuticals plc, filed 2025-12-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | Director | 46 | — | 79 legs · 349,666 sh · $63,985,710 | 44 |
| ACELYRIN, Inc. (SLRN) | Director | 4 | — | — | 9 |
Insider filings — COZADD BRUCE C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-10 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 734 @ $136.18 · Option exercise (M): 85,766 @ $136.18 · Sale (S): 27,714 @ $234.91 · Sale (S): 10,688 @ $235.82 · Sale (S): 24,483 @ $236.84 · Sale (S): 5,923 @ $237.39 · +2 more | EDGAR |
| 2026-11-04 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 6,000 @ $215.84 | EDGAR |
| 2026-10-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 6,000 @ $230.33 | EDGAR |
| 2026-09-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 10 @ $244.06 · Tax withholding (F): 1,209 @ $241.39 · Sale (S): 6,000 @ $250.13 | EDGAR |
| 2026-08-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-08-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 6,000 @ $252.98 | EDGAR |
| 2026-07-06 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 6,000 @ $240.47 | EDGAR |
| 2026-06-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 6,000 @ $235.12 | EDGAR |
| 2026-05-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 6,000 @ $203.33 | EDGAR |
| 2026-04-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 3,684 @ $190.22 · Sale (S): 2,292 @ $190.94 · Sale (S): 24 @ $191.74 | EDGAR |
| 2026-03-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 15,114 @ $188.69 | EDGAR |
| 2026-03-04 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 3,159 @ $186.09 · Sale (S): 2,608 @ $186.73 · Sale (S): 233 @ $187.84 | EDGAR |
| 2026-01-21 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 35,917 @ $0 · Tax withholding (F): 17,453 @ $171.16 | EDGAR |
| 2025-12-01 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 76,689 @ $123.36 · Option exercise (M): 811 @ $123.36 · Sale (S): 30,487 @ $178.06 · Sale (S): 8,380 @ $179.23 · Sale (S): 507 @ $179.79 · Sale (S): 38,126 @ $177.27 · +2 more | EDGAR |
| 2025-11-20 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 3,384 @ $180.09 · Sale (S): 8,382 @ $180.88 · Sale (S): 5,517 @ $181.81 · Sale (S): 717 @ $182.60 · Grant/award (A): 2,506 @ $0 | EDGAR |
| 2025-10-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 2,000 @ $131.78 · Sale (S): 3,500 @ $140 | EDGAR |
| 2025-09-17 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 15,647 @ $126.16 | EDGAR |
| 2025-09-04 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 3,000 @ $127.23 · Sale (S): 3,000 @ $130 | EDGAR |
| 2025-08-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,000 @ $113.21 | EDGAR |
| 2025-07-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 500 @ $105.26 · Sale (S): 500 @ $110 | EDGAR |
| 2025-06-04 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 500 @ $107.90 · Sale (S): 500 @ $110 | EDGAR |
| 2025-05-23 | 4 | ACELYRIN, Inc. (SLRN) | Disposition to issuer (D): 183,434 (derivative) · Disposition to issuer (D): 23,243 (derivative) · Disposition to issuer (D): 92,158 (derivative) | EDGAR |
| 2025-05-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,000 @ $116.35 · Sale (S): 500 @ $120 | EDGAR |
| 2025-04-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,500 @ $123.75 | EDGAR |
| 2025-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Disposition to issuer (D): 22,251 @ $138.95 | EDGAR |
| 2025-03-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 30,814 @ $0 · Sale (S): 6,500 @ $144.25 | EDGAR |
| 2025-02-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,500 @ $122.31 | EDGAR |
| 2025-01-22 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 29,559 @ $0 · Tax withholding (F): 13,840 @ $122.62 | EDGAR |
| 2025-01-06 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,500 @ $123.43 | EDGAR |
| 2024-12-04 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 2,000 @ $121.17 | EDGAR |
| 2024-11-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,000 @ $110.84 | EDGAR |
| 2024-06-11 | 4 | ACELYRIN, Inc. (SLRN) | Grant/award (A): 92,158 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 22,436 @ $117.53 | EDGAR |
| 2024-03-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 50,187 @ $0 | EDGAR |
| 2024-01-19 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 26,545 @ $0 · Tax withholding (F): 12,245 @ $119.13 | EDGAR |
| 2023-05-11 | 4 | ACELYRIN, Inc. (SLRN) | Other (J): 183,434 (derivative) @ $0 · Other (J): 183,434 (derivative) @ $0 · Other (J): 23,243 (derivative) @ $0 · Other (J): 23,243 (derivative) @ $0 | EDGAR |
| 2023-05-04 | 4 | ACELYRIN, Inc. (SLRN) | Grant/award (A): 23,243 (derivative) @ $0 | EDGAR |
| 2023-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 42,388 @ $0 · Tax withholding (F): 21,882 @ $142.78 | EDGAR |
| 2023-02-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,000 @ $155.79 | EDGAR |
| 2023-01-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,000 @ $159.59 · Sale (S): 2,000 @ $160 | EDGAR |
| 2022-12-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,000 @ $157 | EDGAR |
| 2022-11-14 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 2,000 @ $150 | EDGAR |
| 2022-10-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 62,905 @ $59.13 · Sale (S): 13,791 @ $134.02 · Sale (S): 23,646 @ $135.18 · Sale (S): 7,748 @ $135.80 · Option exercise (M): 62,905 (derivative) @ $0 | EDGAR |
| 2022-09-08 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,000 @ $155.10 · Option exercise (M): 9,700 @ $59.13 · Sale (S): 4,517 @ $152.41 · Sale (S): 1,170 @ $153.13 · Sale (S): 474 @ $154.31 · Sale (S): 542 @ $155.22 · +1 more | EDGAR |
| 2022-08-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 9,632 @ $46.83 · Option exercise (M): 68 @ $59.13 · Sale (S): 2,600 @ $153.48 · Sale (S): 2,601 @ $154.50 · Sale (S): 1,100 @ $155.27 · Sale (S): 1,000 @ $154.94 · +2 more | EDGAR |
| 2022-07-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 9,700 @ $46.83 · Sale (S): 5,839 @ $156.65 · Sale (S): 436 @ $157.13 · Sale (S): 1,000 @ $156.95 · Sale (S): 1,500 @ $160 · Option exercise (M): 9,700 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 9,700 @ $46.83 · Sale (S): 2,412 @ $145.42 · Sale (S): 1,360 @ $146.05 · Sale (S): 1,270 @ $148.13 · Sale (S): 831 @ $148.82 · Sale (S): 489 @ $149.68 · +2 more | EDGAR |
| 2022-05-04 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 9,700 @ $46.83 · Sale (S): 1,600 @ $155.34 · Sale (S): 3,177 @ $156.13 · Sale (S): 767 @ $156.97 · Sale (S): 716 @ $158.53 · Sale (S): 1,000 @ $158.67 · +1 more | EDGAR |
| 2022-04-06 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 9,700 @ $46.83 · Sale (S): 1,750 @ $156.33 · Sale (S): 3,228 @ $157.49 · Sale (S): 1,294 @ $158.37 · Sale (S): 1,000 @ $158.64 · Sale (S): 3,500 @ $160 · +1 more | EDGAR |
| 2022-03-21 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 1,288 @ $59.13 · Option exercise (M): 1,288 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1193210 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs